Teva Pharmaceutical Industries Ltd. (TEVA)
32.64
+0.17
(+0.52%)
USD |
NYSE |
Jan 14, 16:00
32.60
-0.04
(-0.12%)
After-Hours: 16:59
Teva Pharmaceutical Industries Market Cap: 37.45B for Jan. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 177.17B |
| Novo Nordisk A/S | 261.81B |
| Compugen Ltd. | 184.26M |
| Pfizer Inc. | 145.44B |
| Can-Fite BioPharma Ltd. | 3.705M |
Market Cap Related Metrics
| PE Ratio | 53.23 |
| PS Ratio | 2.232 |
| Price to Book Value | 5.165 |
| Price to Free Cash Flow | 149.99 |
| Price | 32.64 |
| Earnings Yield | 1.88% |
| Operating PE Ratio | 10.47 |
| Normalized PE Ratio | 19.65 |